Praphulla Chandra Shukla
-
- Cardiac Fibrosis and Remodeling 4
- Cancer Research top 5%
- MicroRNA in disease regulation 4
- Physiology top 10%
- Molecular Biology top 10%
- CRISPR and Genetic Engineering 5
- Mitochondrial Function and Pathology 3
- Signaling Pathways in Disease 3
- Immunology top 10%
- Atherosclerosis and Cardiovascular Diseases 4
-
- PARP inhibition in cancer therapy 4
-
- Adipokines, Inflammation, and Metabolic Diseases 3
- Co-authors
- Subodh VermaAdrian QuanFina LovrenHwee TeohMohammed Al‐OmranKrishna K. SinghYi PanMilan Gupta
- Partner nations
- IndiaCanadaSaudi Arabia
In The Last Decade
Praphulla Chandra Shukla
35 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 100
- Cardiology and Cardiovascular Medicine 555
- Cancer Research 333
- Physiology 352
- Molecular Biology 784
- Immunology 221
Countries citing papers authored by Praphulla Chandra Shukla
This map shows the geographic impact of Praphulla Chandra Shukla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Praphulla Chandra Shukla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Praphulla Chandra Shukla more than expected).
Fields of papers citing papers by Praphulla Chandra Shukla
This network shows the impact of papers produced by Praphulla Chandra Shukla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Praphulla Chandra Shukla. The network helps show where Praphulla Chandra Shukla may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Praphulla Chandra Shukla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 43 | |
| 11 | 2014 | 51 | |
| 12 | 2013 | 54 | |
| 13 | 2013 | 22 | |
| 14 | 2012 | 21 | |
| 15 | 2011 | 115 | |
| 16 | 2011 | 44 | |
| 17 | 2011 | 1 | |
| 18 | 2010 | 37 | |
| 19 | 2009 | 98 | |
| 20 | 2008 | 2 |
About Praphulla Chandra Shukla
Praphulla Chandra Shukla is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine and Genetics, having authored 39 papers that have together received 1.8k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (5 papers), MicroRNA in disease regulation (4 papers), PARP inhibition in cancer therapy (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Cardiac Fibrosis and Remodeling (4 papers), Mitochondrial Function and Pathology (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Signaling Pathways in Disease (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (555 citations), Cancer Research (333 citations) and Physiology (352 citations). Praphulla Chandra Shukla has collaborated with scholars based in India, Canada and Saudi Arabia. Frequent co-authors include Subodh Verma, Adrian Quan, Fina Lovren, Hwee Teoh, Mohammed Al‐Omran, Krishna K. Singh, Yi Pan, Milan Gupta, Mark D. Peterson and Yi Pan.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.